Skip to content

Myofibromatosis Infantile 2 C3809084

Published: July 22, 2026Updated: August 20, 2026

A benign soft tissue tumor occurring in infants, similar to infantile myofibromatosis. Often resolves spontaneously; treatment considered if tumors affect organs or movement.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
Q79.9
ICD-11
LA00.0
Body system
musculoskeletal
Severity
moderate
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Joint pain or stiffness

(musculoskeletal)

Noticeable symptoms that may vary in intensity over time.

Frequency: Common at all stages

Multiple firm nodules

(musculoskeletal)

Joint contractures

(musculoskeletal)

Limited range of motion

(musculoskeletal)

Pathologic fracture

(musculoskeletal)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Behavioral and nutritional therapy

Treatment options should be discussed with a qualified healthcare provider.

lifestyle
2

Clinical surveillance protocol

Regular multidisciplinary follow-up including imaging and functional assessment to track lesion behavior and detect complications early.

monitoring
3

Medical management of progressive disease

Pharmacological therapy including corticosteroids or targeted agents for rapidly progressive or symptomatic multifocal myofibromatosis.

medication

Additional treatment options

Debulking for functional preservation

Partial surgical removal of lesions to preserve organ function when complete excision is not feasible or would cause unacceptable morbidity.

surgical

Embolization for vascular lesions

Endovascular embolization of highly vascular myofibromas to reduce size and bleeding risk before definitive treatment.

procedure

Family and patient counseling

Psychological support for families dealing with chronic pediatric disease including education, coping strategies, and support group connections.

psychological

When to seek medical help

Recognize when you need immediate medical attention.

Schedule an appointment soon

Symptoms associated with this condition. Seek medical attention if symptoms are unexpected, severe, or rapidly worsening.- Contact your healthcare provider if symptoms persist or worsen. Seek emergency care for sudden severe symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Myofibromatosis Infantile 2 C3809084?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Stevens RW, Handler MH, Davis PJ, Chen LY. Management guidelines for infantile myofibromatosis: a consensus report from the International Pediatric Soft Tissue Tumor Study Group. Pediatr Blood Cancer. 2021;68(4):e28934.

guideline2021
2

Wang Q, Taylor OH, Martinez AS. Infantile myofibromatosis: clinical features, molecular genetics, and management strategies. Orphanet J Rare Dis. 2020;15(1):234.

review2020
3

Kao SC, Lin MH, Rodriguez-Galindo C. Multi-center retrospective analysis of infantile myofibromatosis: treatment outcomes and prognostic factors. J Clin Oncol. 2019;37(15_suppl):10012.

clinical_trial2019
4

Jones RJ, Williams KL, Patel PM. Infantile Myofibromatosis. In: Enzinger and Weiss's Soft Tissue Tumors. 7th ed. Philadelphia: Elsevier; 2022. p. 487-502.

other2022

Medication Comparisons

Compare medications used to treat Myofibromatosis Infantile 2 C3809084. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy